Review



mouse anti human cd66a pe  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems mouse anti human cd66a pe
    Mouse Anti Human Cd66a Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+cd66a+pe/pmc11637558-70-28-33?v=R%26D+Systems
    Average 94 stars, based on 11 article reviews
    mouse anti human cd66a pe - by Bioz Stars, 2026-07
    94/100 stars

    Images



    Similar Products

    94
    R&D Systems mouse anti human cd66a pe
    Mouse Anti Human Cd66a Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+cd66a+pe/pmc11637558-70-28-33?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    mouse anti human cd66a pe - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    93
    R&D Systems ceacam1 mouse igg2b n a pe r d systems
    Ceacam1 Mouse Igg2b N A Pe R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+cd66a+pe/pmc10427345-206-8-13?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    ceacam1 mouse igg2b n a pe r d systems - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    94
    R&D Systems ic002p anti ceacam1 antibody human ceacam1 cd66a r d systems
    Ic002p Anti Ceacam1 Antibody Human Ceacam1 Cd66a R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+cd66a+pe/us11332528-390-22-27?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    ic002p anti ceacam1 antibody human ceacam1 cd66a r d systems - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    93
    R&D Systems phycoerythrin pe conjugated mouse anti human ceacam1 mab
    Figure 2. Expression of <t>CEACAM1</t> on the surface of T cells in first trimester human decidua and in the PB of healthy non-pregnant and pregnant females. (A) The percentages of CEACAM1+ cells among CD4+ T cells, CD8+ T cells, CD4+CD45RO+ T cells and CD8+CD45RO+ T cells are shown. The percentage of CD4+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) or pregnant females (P<0.001). The percentage of CD8+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P=0.004) or pregnant females (P=0.01). The percentage of CD4+CD45RO+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) and pregnant females (P=0.001). The percentage of CD8+CD45RO+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) and pregnant females (P<0.001). Data are presented as the mean ± SD. *P<0.05. (B) The isolated lymphocytes were analyzed for phenotypic frequency by flow cytometry. CD4+CD45RO+ and CD8+CD45RO+ T cells were individually gated and further analysis was conducted. Markers were set according to CEACAM1. PB, peripheral blood; CEACAM1, carcinoembryonic antigen-related cell adhesion molecule 1.
    Phycoerythrin Pe Conjugated Mouse Anti Human Ceacam1 Mab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+human+cd66a+pe/pm23799589-41-21-27?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    phycoerythrin pe conjugated mouse anti human ceacam1 mab - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    Figure 2. Expression of CEACAM1 on the surface of T cells in first trimester human decidua and in the PB of healthy non-pregnant and pregnant females. (A) The percentages of CEACAM1+ cells among CD4+ T cells, CD8+ T cells, CD4+CD45RO+ T cells and CD8+CD45RO+ T cells are shown. The percentage of CD4+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) or pregnant females (P<0.001). The percentage of CD8+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P=0.004) or pregnant females (P=0.01). The percentage of CD4+CD45RO+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) and pregnant females (P=0.001). The percentage of CD8+CD45RO+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) and pregnant females (P<0.001). Data are presented as the mean ± SD. *P<0.05. (B) The isolated lymphocytes were analyzed for phenotypic frequency by flow cytometry. CD4+CD45RO+ and CD8+CD45RO+ T cells were individually gated and further analysis was conducted. Markers were set according to CEACAM1. PB, peripheral blood; CEACAM1, carcinoembryonic antigen-related cell adhesion molecule 1.

    Journal: Molecular medicine reports

    Article Title: Expansion of decidual CD45RO⁺ T cells with high expression of CEACAM1 in the early stage of pregnancy.

    doi: 10.3892/mmr.2013.1552

    Figure Lengend Snippet: Figure 2. Expression of CEACAM1 on the surface of T cells in first trimester human decidua and in the PB of healthy non-pregnant and pregnant females. (A) The percentages of CEACAM1+ cells among CD4+ T cells, CD8+ T cells, CD4+CD45RO+ T cells and CD8+CD45RO+ T cells are shown. The percentage of CD4+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) or pregnant females (P<0.001). The percentage of CD8+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P=0.004) or pregnant females (P=0.01). The percentage of CD4+CD45RO+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) and pregnant females (P=0.001). The percentage of CD8+CD45RO+CEACAM1+ T cells in the decidua was significantly increased compared with that in the PB from non-pregnant females (P<0.001) and pregnant females (P<0.001). Data are presented as the mean ± SD. *P<0.05. (B) The isolated lymphocytes were analyzed for phenotypic frequency by flow cytometry. CD4+CD45RO+ and CD8+CD45RO+ T cells were individually gated and further analysis was conducted. Markers were set according to CEACAM1. PB, peripheral blood; CEACAM1, carcinoembryonic antigen-related cell adhesion molecule 1.

    Article Snippet: Fluorescein isothiocyanate (FITC)-conjugated mouse anti-human CD4 monoclonal antibody (mAb) (Jingmei Biological, Co., Beijing, China), CD8 mAb (Becton-Dickinson, Franklin Lakes, NJ, USA), phycoerythrin (PE)-conjugated mouse anti-human CEACAM1 mAb (R&D Systems, Minneapolis, MN, USA), PE-cyanine (Cy) 5-conjugated mouse anti-human CD45RO mAb (Jingmei Biological Co.) and their isotype- and fluorochrome-matched control antibodies, were used for flow cytometry.

    Techniques: Expressing, Isolation, Flow Cytometry

    Figure 5. Expression of CEACAM1 on the surface of CD45RO+ T cells in the induced CD45RO+ T cell model. (A) The percentages of CD4+CD45RO+ and CD8+CD45RO+ T cells expressing CEACAM1 in the induced CD45RO+ T cell model are shown. The experiments were performed three times. The propor tion of CEACAM1-expressing CD4+CD45RO+ T cells was significantly increased in the group with conditioned medium from the coculture of monocytes and the human trophoblast HTR8/SVneo cell line (the MHM group) compared with the control group (P=0.02). The proportion of CEACAM1-expressing CD4+CD45RO+ T cells was not significantly decreased in the MHM + anti‑MCP‑1 group, compared with that in the MHM group; however, that proportion was significantly increased by human recombinant MCP‑1 (rhMCP‑1) compared with the control group (P=0.017). The proportion of CEACAM1-expressing CD8+CD45RO+ T cells did not show a statistically significant difference among the four groups (P=0.303). Data are presented as the mean ± SD. *P<0.05. (B) The lymphocytes were analyzed for phenotypic frequency by flow cytometry. CD4+CD45RO+ and CD8+CD45RO+ T cells were individually gated and further analysis was conducted. Markers were set according to the CEACAM1‑isotype IgG. CEACAM1, carcinoembryonic antigen-related cell adhesion molecule 1; MCP-1, monocyte chemoattractant protein-1.

    Journal: Molecular medicine reports

    Article Title: Expansion of decidual CD45RO⁺ T cells with high expression of CEACAM1 in the early stage of pregnancy.

    doi: 10.3892/mmr.2013.1552

    Figure Lengend Snippet: Figure 5. Expression of CEACAM1 on the surface of CD45RO+ T cells in the induced CD45RO+ T cell model. (A) The percentages of CD4+CD45RO+ and CD8+CD45RO+ T cells expressing CEACAM1 in the induced CD45RO+ T cell model are shown. The experiments were performed three times. The propor tion of CEACAM1-expressing CD4+CD45RO+ T cells was significantly increased in the group with conditioned medium from the coculture of monocytes and the human trophoblast HTR8/SVneo cell line (the MHM group) compared with the control group (P=0.02). The proportion of CEACAM1-expressing CD4+CD45RO+ T cells was not significantly decreased in the MHM + anti‑MCP‑1 group, compared with that in the MHM group; however, that proportion was significantly increased by human recombinant MCP‑1 (rhMCP‑1) compared with the control group (P=0.017). The proportion of CEACAM1-expressing CD8+CD45RO+ T cells did not show a statistically significant difference among the four groups (P=0.303). Data are presented as the mean ± SD. *P<0.05. (B) The lymphocytes were analyzed for phenotypic frequency by flow cytometry. CD4+CD45RO+ and CD8+CD45RO+ T cells were individually gated and further analysis was conducted. Markers were set according to the CEACAM1‑isotype IgG. CEACAM1, carcinoembryonic antigen-related cell adhesion molecule 1; MCP-1, monocyte chemoattractant protein-1.

    Article Snippet: Fluorescein isothiocyanate (FITC)-conjugated mouse anti-human CD4 monoclonal antibody (mAb) (Jingmei Biological, Co., Beijing, China), CD8 mAb (Becton-Dickinson, Franklin Lakes, NJ, USA), phycoerythrin (PE)-conjugated mouse anti-human CEACAM1 mAb (R&D Systems, Minneapolis, MN, USA), PE-cyanine (Cy) 5-conjugated mouse anti-human CD45RO mAb (Jingmei Biological Co.) and their isotype- and fluorochrome-matched control antibodies, were used for flow cytometry.

    Techniques: Expressing, Control, Recombinant, Flow Cytometry